These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 21318534)

  • 1. Transglutaminase-catalyzed formation of Alzheimer-like insoluble complexes from recombinant tau.
    Balin BJ; Appelt DM
    Methods Mol Med; 2000; 32():395-404. PubMed ID: 21318534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of tissue transglutaminase with human recombinant tau results in the formation of insoluble filamentous structures.
    Appelt DM; Balin BJ
    Brain Res; 1997 Jan; 745(1-2):21-31. PubMed ID: 9037390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of paired helical filaments (PHFs) found in Alzheimer's disease using freeze-drying/rotary shadowing.
    Appelt DM; Balin BJ
    J Struct Biol; 1993; 111(2):85-95. PubMed ID: 8130039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of paired helical filaments by scanning transmission electron microscopy.
    Ksiezak-Reding H; Wall JS
    Microsc Res Tech; 2005 Jul; 67(3-4):126-40. PubMed ID: 16104001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibrillary pathology and aluminum in Alzheimer's disease.
    Shin RW; Lee VM; Trojanowski JQ
    Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of antigenic determinants that distinguish neurofibrillary tangles in progressive supranuclear palsy and Alzheimer's disease.
    Schmidt ML; Lee VM; Hurtig H; Trojanowski JQ
    Lab Invest; 1988 Oct; 59(4):460-6. PubMed ID: 2459498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granular tau oligomers as intermediates of tau filaments.
    Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
    Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration.
    Pei JJ; Braak H; Gong CX; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
    Acta Neuropathol; 2002 Oct; 104(4):369-76. PubMed ID: 12200623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein.
    Wang Q; Woltjer RL; Cimino PJ; Pan C; Montine KS; Zhang J; Montine TJ
    FASEB J; 2005 May; 19(7):869-71. PubMed ID: 15746184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex.
    Mawal-Dewan M; Schmidt ML; Balin B; Perl DP; Lee VM; Trojanowski JQ
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1051-9. PubMed ID: 8858002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR.
    Ma QF; Li YM; Du JT; Kanazawa K; Nemoto T; Nakanishi H; Zhao YF
    Biopolymers; 2005 Oct; 79(2):74-85. PubMed ID: 15986501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.
    Goedert M; Jakes R; Spillantini MG; Hasegawa M; Smith MJ; Crowther RA
    Nature; 1996 Oct; 383(6600):550-3. PubMed ID: 8849730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
    Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
    Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecules of the quinoline family block tau self-aggregation: implications toward a therapeutic approach for Alzheimer's disease.
    Navarrete LP; Guzmán L; San Martín A; Astudillo-Saavedra L; Maccioni RB
    J Alzheimers Dis; 2012; 29(1):79-88. PubMed ID: 22232002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease.
    Marcus JN; Schachter J
    J Neurogenet; 2011 Dec; 25(4):127-33. PubMed ID: 22091726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.
    Schneider A; Biernat J; von Bergen M; Mandelkow E; Mandelkow EM
    Biochemistry; 1999 Mar; 38(12):3549-58. PubMed ID: 10090741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice.
    Ishihara T; Zhang B; Higuchi M; Yoshiyama Y; Trojanowski JQ; Lee VM
    Am J Pathol; 2001 Feb; 158(2):555-62. PubMed ID: 11159192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain.
    Barghorn S; Davies P; Mandelkow E
    Biochemistry; 2004 Feb; 43(6):1694-703. PubMed ID: 14769047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments.
    Jeganathan S; von Bergen M; Mandelkow EM; Mandelkow E
    Biochemistry; 2008 Oct; 47(40):10526-39. PubMed ID: 18783251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.